Congestive Heart Failure News and Research

RSS

Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.

Supervised exercise training at moderate intensity improves prognosis for heart failure

Contrary to what was previously assumed, physical exercise does not lead to harmful ventricular enlargement.

21 Feb 2017

New bed sensors can warn older adults of impending heart problems

Congestive heart failure is one of the most common reasons for hospital admissions among those 65 years old and older, according to the Centers for Disease Control and Prevention.

14 Feb 2017

Scientists identify gene variants that predispose children to developing Kawasaki disease

Kawasaki disease (KD) is the most common acquired heart disease in children. Untreated, roughly one-quarter of children with KD develop coronary artery aneurysms -- balloon-like bulges of heart vessels -- that may ultimately result in heart attacks, congestive heart failure or sudden death.

9 Feb 2017

Cancer drug could promote regeneration of damaged heart muscle, research shows

An anticancer agent in development promotes regeneration of damaged heart muscle 0- an unexpected research finding that may help prevent congestive heart failure in the future.

3 Feb 2017

‘Love hormone’ from insects could be used as drug lead to prevent uterine contractility in preterm labour

In a recent study published in "Scientific Reports", an international team of researchers led by MedUni Vienna report that an oxytocin-like neuropeptide ("inotocin") exhibited a specific pharmacological profile for the human receptors of oxytocin (known as the "love hormone") and vasopressin.

1 Feb 2017

TUM researchers decipher secret behind cohesion of heart muscles

Our hearts beat a life long. With every beat our heart muscle contracts and expands. How this can work throughout an entire life remains largely a mystery. Researchers at the Technical University of Munich have now measured the forces acting between the building blocks titin and α-actinin which stabilize the muscle.

25 Jan 2017

Important vaccines that should not be missed by adults, elders and pregnant women

Vaccines are an important part of routine healthcare for adults, seniors and women who are pregnant.

16 Jan 2017

Researchers develop novel tests that could improve treatment for heart failure patients

For the first time, researchers have developed tests that could improve treatment for heart failure patients by diagnosing the condition with greater accuracy, as well as by detecting the onset of congestive heart failure earlier.

5 Jan 2017

Alcohol abuse linked to increased risk of heart conditions

Alcohol abuse increases the risk of atrial fibrillation, heart attack and congestive heart failure as much as other well-established risk factors such as high blood pressure, diabetes, smoking and obesity, according to a study published today in the Journal of the American College of Cardiology.

3 Jan 2017

Financial penalties can reduce hospital readmissions

Hospitals that were financially penalized for too many readmissions were more likely than non-penalized institutions to subsequently reduce readmissions for all conditions, according to a new study by Yale School of Medicine researchers and colleagues in the Journal of the American Medical Association.

30 Dec 2016

ACA financial penalties lead to reductions in hospital readmission rates for common conditions

Financial penalties levied under the Affordable Care Act's Hospital Readmissions Reduction Program lead to the poorest performing hospitals to achieve the greatest reductions in readmission rates for common conditions.

27 Dec 2016

Studies show how overactive immune response may contribute to heart disease in psoriasis patients

Psoriasis is well-known for causing too many skin cells on elbows, knees, and across the body, but people living with psoriasis may also be at an increased risk of heart disease.

9 Dec 2016

Iron deficiency: an interview with Dr Thierry Teil

Iron deficiency is, in fact, one of the most common nutritional disorders. It affects between three and five billion people, which is between half and two-thirds of the world population (about seven billion). Iron deficiency anemia is a subset of iron deficiency, that is about two billion people according to the WHO...

From CSL Ltd 30 Nov 2016

2nd Global Iron Deficiency Day: Vifor Pharma supports global activities to raise awareness of iron deficiency

According to the World Health Organisation, iron deficiency affects up to one-third of the world's population, and is particularly common in elderly individuals and those with certain chronic diseases such as chronic kidney disease, congestive heart failure or inflammatory bowel disease.

From CSL Ltd 25 Nov 2016

Research finds low rates of oral anticoagulant use in hospitalized atrial fibrillation patients

When patients suffer from atrial fibrillation, an irregular heartbeat, they are at considerably higher risk for blood clots and stroke.

14 Nov 2016

Lower drug copays lead to reduction in hospitalizations among indigenous people in Australia

A new study finds that in regions where indigenous Australians most readily accepted a government incentive to lower drug copayments, hospitalizations to treat the population's chronic conditions declined by 40 percent in just two years.

8 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

Pennsylvania hospitals reduce mortality rates for ten common health conditions, new report reveals

Pennsylvania hospitals continue to improve quality and drive down mortality and readmission rates according to a new report released today by the Pennsylvania Health Care Cost Containment Council (PHC4).

20 Oct 2016

New report underscores personal and economic impact of IBS

A multi-disciplinary expert group calls for greater attention to be paid to Irritable Bowel Syndrome (IBS) to bring it out of the shadows. The IBS Global Impact Report is launched at United European Gastroenterology Week and examines published studies on the direct and indirect costs of IBS.

19 Oct 2016

Mouths of migraine sufferers harbor more nitrate-reducing bacteria, study finds

Researchers at University of California San Diego School of Medicine have found that the mouths of migraine sufferers harbor significantly more microbes with the ability to modify nitrates than people who do not get migraine headaches.